Overview
HRMY market data
Price History
HRMY price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for HRMY. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
HC Wainwright & Co. Reiterates Buy on Harmony Biosciences Hldgs, Maintains $55 Price TargetBenzinga · Jul 16, 2026, 4:24 PM
Harmony Biosciences Reports Preliminary Q2 WAKIX Sales Of ~$261M, Up 30% YoY; Appoints Stephen Mollichella As Interim CFOBenzinga · Jul 16, 2026, 12:40 PM
Harmony Biosciences Hldgs Affirms Prelim FY2026 Sales Guidance of $1.000B-$1.040B vs $1.014B EstBenzinga · Jul 16, 2026, 12:38 PM
8-K filing — Harmony Biosciences Holdings, Inc. (HRMY)SEC EDGAR · Jul 16, 2026, 12:35 PM
Deutsche Bank Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $36Benzinga · Jun 30, 2026, 5:20 PM
A beaten-down biotech just lost a meaningful backer — should you care?The Motley Fool · May 19, 2026, 10:15 PM